Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO Study
NCT00381030Phase 4Completed
- Sponsor
- Denver Health
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in heart failure (HF) (2 arms), sponsored by Denver Health. Primary endpoint: Time to Death or Heart Failure Hospitalization. Started Oct 2002; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00381030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381030.